Subscribe to Newsletter

Search

Reset Filter

920 search results for ‘*’

Alexander Mullen

Co-founder and Chief Scientific Officer, Fitabeo Therapeutics Mullen is a Professor of Pharmacy at the University of Strathclyde and a GPhC UK registered pharmacist with 30 years of experience in clin

Matt Clark

CEO, X-Chem Matt Clark is a recognized innovator and leader in the DNA-encoded library (DEL) field. He was part of X-Chem’s founding team where he served as VP Chemistry and SVP Research prior to his

Sharon L. Rogers

CEO, AmyriAD Rogers brings the strength of 35 years of pharma experience to AmyriAD . She is best known as the worldwide leader of and development strategist behind the highly successful Alzheimer’s t

Robert Lee

President, Lubrizol Life Sciences – CDMO Division Lee holds more than two dozen issued patents or provisional patent applications and, through his more than 30 years’ experience in pharmaceutical rese

Rebecca Guntern

Vice President, Medicines for Europe; Head of Europe, Sandoz International Rebecca Guntern-Flückiger is a purpose-driven leader and a regular contributor to industry discussions and initiatives. She i

Anne Phelan

Chief Scientific Officer, BenevolentAI Phelan is responsible for all aspects of drug discovery from therapeutics selection to candidate nomination and clinical development, and also acts in the capaci

Edward Haeggström

CEO, Nanoform A former Harvard visiting professor with an academic portfolio consisting of over 400 papers and 25 patents/patent applications, Hæggström is renowned within the scientific community. He

Francis Burrows

Senior Vice President, Translational Research, Kura Oncology Burrows is a drug discovery and development scientist with over twenty years’ experience in small and large biotech companies. Throughout h

Christopher J. Schaber

Chairman, President, and CEO, Soligenix Christopher J. Schaber has over 30 years of experience in the pharmaceutical and biotechnology industry. He also serves on the board of directors of the Biotech

Pfizer

Best Big Pharma Company Pfizer retains its crown this year as your number one big pharma company. In 2022, the company’s revenues hit an all time high of $100.3 billion (an increase of 23 percent comp

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register